These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20569940)

  • 21. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
    Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and NSAID induced gastropathy.
    Zeidler H
    J Rheumatol Suppl; 1991 Mar; 28():2-5. PubMed ID: 2038013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
    Targownik LE; Metge CJ; Leung S; Chateau DG
    Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?
    McCarthy DM
    Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs.
    Harris CL; Raisch DW; Abhyankar U; Marfatia S; Campbell HM; Sather MR
    Ann Pharmacother; 2006 Nov; 40(11):1924-31. PubMed ID: 17047140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs).
    Valkhoff VE; van Soest EM; Sturkenboom MC; Kuipers EJ
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1218-28. PubMed ID: 20222917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NSAID-related upper gastrointestinal bleeding: are risk factors considered during prophylaxis?
    Dincer D; Duman A; Dikici H; Arici C; Suleymanlar I; Isitan F
    Int J Clin Pract; 2006 May; 60(5):546-8. PubMed ID: 16700851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines.
    Laine L; Connors L; Griffin MR; Curtis SP; Kaur A; Cannon CP
    Aliment Pharmacol Ther; 2009 Oct; 30(7):767-74. PubMed ID: 19594486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
    Wilcox CM; Shalek KA; Cotsonis G
    Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-inflammatory drug therapy in primary care: a cross-sectional study.
    Morini S; Zullo A; Oliveti D; Chiriatti A; Marmo R; Chiuri DA; Marotti G; Morelli L; Hassan C
    J Clin Gastroenterol; 2011 Oct; 45(9):780-4. PubMed ID: 21918387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antisecretory drugs and prophylaxis of secondary gastrointestinal effects associated with the consumption of non steroid anti-inflammatory drugs].
    Lanas A; Arroyo MT
    Med Clin (Barc); 2000; 114 Suppl 2():57-62. PubMed ID: 10916808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
    Etminan M; Lévesque L; Fitzgerald JM; Brophy JM
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1188-92. PubMed ID: 19298582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
    Scheiman JM; Hindley CE
    Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs.
    Abraham NS; El-Serag HB; Johnson ML; Hartman C; Richardson P; Ray WA; Smalley W
    Gastroenterology; 2005 Oct; 129(4):1171-8. PubMed ID: 16230071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
    Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B
    Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
    Lanas A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
    Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
    N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users.
    Murthy SK; Kauldher S; Targownik LE
    Aliment Pharmacol Ther; 2006 May; 23(9):1365-72. PubMed ID: 16629943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.